Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients

Transpl Immunol. 2010 Oct;24(1):40-4. doi: 10.1016/j.trim.2010.10.001. Epub 2010 Oct 19.

Abstract

Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is a member of the immunoglobulin superfamily. CTLA4, which binds to B7 molecules on antigen- presenting cells, is expressed on activated T cells, thereby delivering negative signals that down-regulate T-cell proliferation and cytokine production. Consequently, CTLA4 may be a good candidate gene to evaluate in kidney transplantation rejection. In this study, we investigated whether polymorphisms of the CTLA4 gene were associated with susceptibility to kidney transplantation rejection. We genotyped three selected SNPs in the CTLA4 gene using direct sequencing in 325 renal transplant recipients. Of the SNPs examined, one (rs231775) showed a statistical association with late acute rejection (p=0.026, odds ratio (OR)=0.48, 95% confidence interval (CI)=0.23-0.93 in the dominant model). Also, the frequency of the G allele (rs231775) was higher in late acute rejection patients (p=0.013, OR=2.02, 95% CI=1.15-3.52). One CTLA4 gene polymorphism was associated with susceptibility to late acute rejection in kidney transplantation in Korean patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Antigens, CD / genetics*
  • Antigens, CD / immunology
  • CTLA-4 Antigen
  • DNA Mutational Analysis
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Graft Rejection / genetics*
  • Graft Rejection / immunology
  • Graft Rejection / metabolism
  • Histocompatibility
  • Humans
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Republic of Korea

Substances

  • Antigens, CD
  • CTLA-4 Antigen
  • CTLA4 protein, human